Related Experiment Video
Updated: Sep 27, 2025

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
Published on: December 1, 2023
Post-COVID-19 Longitudinally Extensive Transverse Myelitis with Myelin Oligodendrocyte Glycoprotein Antibodies
Ellen Yang1, Adnan Husein1, Jose Martinez-Perez1
1Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA.
Background:
Myelin oligodendrocyte glycoprotein (MOG) antibody disease most commonly presents with optic neuritis, though myelitis is also possible. It is rare in the post-infectious and particularly post-COVID-19 setting. Case Presentation. We present the case of a 57-year-old man who tested positive for COVID-19 and experienced respiratory symptoms that completely resolved within one week. About 3 weeks after testing positive, he began experiencing acute onset anuria, followed by lower extremity paresthesia and paraparesis, which progressed to bilateral lower extremity paraplegia, complete loss of sensation of pain, temperature, vibration, and proprioception, and a T4 sensory level. He was initially diagnosed with and treated for acute inflammatory demyelinating polyradiculoneuropathy (AIDP), after which he made minimal clinical improvement. The diagnosis was shifted to longitudinally extensive transverse myelitis, and his CSF tested positive for MOG antibodies. He is being treated with a steroid regimen and extensive outpatient physical therapy.
Conclusion:
The neurologic manifestations of COVID-19 are still being uncovered. Neurologic symptoms should be included in patient education on symptom monitoring, even after recovery of respiratory illness, so that COVID-19-related CNS pathology can be urgently treated.
Insights
A rare case of myelin oligodendrocyte glycoprotein (MOG) antibody disease presented as severe myelitis following COVID-19 infection. This highlights the need for urgent diagnosis and treatment of post-COVID-19 neurological complications.
Area of Science:
- Neurology
- Immunology
- Infectious Diseases
Background:
- Myelin oligodendrocyte glycoprotein (MOG) antibody disease typically presents as optic neuritis, but myelitis is also a possible manifestation.
- Neurological complications following COVID-19 infection are increasingly recognized, though MOG antibody disease in this context is rare.
Observation:
- A 57-year-old man developed acute anuria, paresthesia, and paraplegia three weeks after resolving COVID-19 symptoms.
- Initial diagnosis of acute inflammatory demyelinating polyradiculoneuropathy (AIDP) led to minimal improvement.
Findings:
- The patient was diagnosed with longitudinally extensive transverse myelitis.
- Cerebrospinal fluid analysis confirmed the presence of MOG antibodies.
Implications:
- This case underscores the importance of considering MOG antibody disease in patients with myelitis post-COVID-19.
- Early diagnosis and treatment, including steroids and physical therapy, are crucial for managing these rare neurological sequelae.
More Related Videos
Related Concept Videos
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Myocarditis II: Clinical Features and Diagnostic Tests

